Bull
$10.84
シナリオ価格
$11.980
+0.060 (+0.50%)終値時点
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
Deutsche Bank
$9
2025-02-28
Deutsche Bank
2025-02-28
目標株価
$9
Truist Securities
$12
2025-01-31
Truist Securities
2025-01-31
目標株価
$12
Truist Securities
$13
2025-01-16
Truist Securities
2025-01-16
目標株価
$13
RBC Capital
$12
2025-01-15
RBC Capital
2025-01-15
目標株価
$12
B of A Securities
$8.5
2025-01-13
B of A Securities
2025-01-13
目標株価
$8.5
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Rising Menstrual Product Prices Squeeze Consumers

Oil Prices Rise, Boosting Stock Market Performance

Walgreens Lays Off 469 Employees Amid Business Reorganization

Dow Jones Index Surpasses 50,000 for the First Time

Analysis of Store Openings and Closures in U.S. Retail Sector
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey. It operates in the Consumer Non-Cyclicals sector (RETAIL-DRUG STORES AND PROPRIETARY STORES industry).
24 analysts cover WBA: 15 rate it Buy, 9 Hold and 0 Sell. The average price target is 11.45.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。